n Gender and Behaviour - Chemotherapy and chemoprophylaxis of malaria in pregnancy in private and public facilities : perceptions and use by pregnant women in Enugu State, Nigeria
|Article Title||Chemotherapy and chemoprophylaxis of malaria in pregnancy in private and public facilities : perceptions and use by pregnant women in Enugu State, Nigeria|
|© Publisher:||IFE Centre for Psychological Studies (ICPS)|
|Journal||Gender and Behaviour|
|Affiliations||1 University of Nigeria Teaching Hospital, 2 University of Nigeria Teaching Hospital and 3 University of Lagos, Nigeria|
|Publication Date||Jan 2013|
|Pages||5688 - 5697|
|Keyword(s)||Chemoprevention, Chemotherapy, IPTp and Malaria-in-pregnancy|
The current recommendation by WHO to control malaria in pregnancy (MIP) in areas of stable malaria transmission relies on prompt and effective case management of malaria, the use of Intermittent preventive treatment (IPTp) of malaria using sulphadoxine-pyrimethamine (SP). The objective of the study was to assess the perceptions about MIP, nature of chemoprophylaxis and chemotherapy of MIP, especially level of acceptability and use of IPTp by pregnant women attending public and private health facilities. The study was undertaken in Enugu, southeast Nigeria. Data was collected from pregnant women attending antenatal clinics in selected private and public health facilities, which were two busiest public and private hospitals. A total of 647 consenting pregnant women (321 in the public hospitals and 326 in the private hospitals) were administered with well structured questionnaires. Tabulations were used to compute nature of perceptions, levels of acceptability and use of IPTp amongst the pregnant women. Bivariate analysis was used to examine whether the differences in the variables between pregnant women attending public and private facilities were statistically significant. The general malaria knowledge was high among both the consumers although the pregnant women attending private hospitals were less aware of IPTp as a preventive strategy for MIP (p<0.05). There was no significant difference in the acceptability of IPTp by the pregnant women in public and private facilities (p>0.05). IPTp was consumed more by pregnant women in the private facilities (76.9%) compared to those in the public facilities (27.6%) (p<0.05). Blood tests were used more by consumers in the private facilities (71.3%) compared to those in the public facilities (50.2%) (p<0.05). The level of knowledge about MIP was high among the pregnant women. However, health seeking behaviour for MIP by pregnant women attending private facilities was better than those attending public facilities. Hence, interventions are needed to improve the management of MIP in public facilities, and also enhancing the services of private providers.
Article metrics loading...